Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio
29 déc. 2017 09h25 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting...
Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote
14 déc. 2017 17h03 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), (“Galena”) announced today that its special meeting of stockholders (“Special Meeting”), scheduled for...
Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017
08 déc. 2017 14h50 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination...
Galena Biopharma Reports Third Quarter 2017 Financial Results
09 nov. 2017 16h30 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab
28 sept. 2017 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
11 sept. 2017 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Reports Second Quarter 2017 Financial Results
14 août 2017 16h30 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group
08 août 2017 06h00 HE
|
Galena Biopharma, Inc.
Merger to create a late-stage, NASDAQ-listed company focused on developing novel immune therapies for various types of cancerSELLAS’ lead asset, galinpepimut-S (GPS), is a Wilm’s Tumor 1...
Galena Biopharma Provides Corporate Update
12 juil. 2017 06h30 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
Galena Biopharma Reports First Quarter 2017 Financial Results
10 mai 2017 16h30 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...